Siemens Healthineers’ Syngo.CT Coronary Cockpit uses coronary CT angiography data to support treatment decisions and intervention planning.


Siemens Healthineers has received US Food and Drug Administration (FDA) clearance for Syngo.CT Coronary Cockpit, a software solution that supports management of coronary artery disease using coronary CT angiography data. The software automates analysis of coronary plaque to support clinical decision-making and percutaneous coronary intervention planning, according to the company.

Syngo.CT Coronary Cockpit resides within the Syngo.via imaging software platform and uses AI-based segmentation, labeling, and visualization to characterize the amount and morphology of plaque. Clinicians can review plaque across the entire coronary tree or within individual lesions.

Information on plaque composition, size, and distribution can help clinicians assess patient risk and decide whether intervention or medical management is appropriate, according to Siemens Healthineers.

“With Syngo.CT Coronary Cockpit, clinicians can obtain advanced insights from a patient’s CT scan to support a more comprehensive assessment of cardiac health and better inform treatment decisions, ultimately helping people with coronary artery disease live longer, healthier lives,” says Olivia Egan, head of computed tomography at Siemens Healthineers North America, in a release.

Addressing Avoidable Invasive Procedures

Coronary artery disease is the most common form of heart disease, which is the leading cause of death in the US and worldwide, according to the US Centers for Disease Control and Prevention. Siemens Healthineers notes that patients with suspected or known coronary artery disease often undergo invasive diagnostic procedures in the cath lab that additional information could have helped avoid.

Advances in dual-source and photon-counting CT technology have made noninvasive coronary CT angiography a frontline diagnostic tool. The company says that using the technology with its dual-source Naeotom Alpha photon-counting CT scanner can reduce diagnostic angiography referrals by more than 50%, lower costs, and shorten hospital stays, citing the value of coronary CT angiography in assessing plaque visibility. The company points to two studies published in Radiology and Radiology: Cardiothoracic Imaging to support the claim.

The software is designed to support workflow efficiency across the coronary artery disease care pathway using coronary CT angiography data from any CT scanner. Using it with Siemens Healthineers dual-source and photon-counting CT systems offers added benefits, the company says. Those benefits include the high native temporal resolution of dual-source technology and the ultra-high spatial resolution of the Naeotom Alpha class.

Photo caption: Syngo.CT Coronary Cockpit

Photo credit: Siemens Healthineers